Quartin AA, Scerpella EG, Puttagunta S, Kett DH. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis. 2013;13:561. https://doi.org/10.1186/1471-2334-13-561.
Article PubMed PubMed Central Google Scholar
Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582–610. https://doi.org/10.1128/cmr.00040-09.
Article CAS PubMed PubMed Central Google Scholar
Sawa T, Shimizu M, Moriyama K, Wiener-Kronish JP. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Crit Care. 2014;18(6):668. https://doi.org/10.1186/s13054-014-0668-9.
Article PubMed PubMed Central Google Scholar
Behzadi P, Baráth Z, Gajdács M. It’s not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiotics. 2021. https://doi.org/10.3390/antibiotics10010042.
Article PubMed PubMed Central Google Scholar
Saharman YR, Pelegrin AC, Karuniawati A, Sedono R, Aditianingsih D, Goessens WHF, et al. Epidemiology and characterisation of carbapenem-non-susceptible Pseudomonas aeruginosa in a large intensive care unit in Jakarta, Indonesia. Int J Antimicrob Agents. 2019;54(5):655–60. https://doi.org/10.1016/j.ijantimicag.2019.08.003.
Article CAS PubMed Google Scholar
Qin J, Zou C, Tao J, Wei T, Yan L, Zhang Y, et al. Carbapenem resistant Pseudomonas aeruginosa infections in elderly patients: antimicrobial resistance profiles, risk factors and impact on clinical outcomes. Infect Drug Resist. 2022;15:2301–14. https://doi.org/10.2147/idr.S358778.
Article PubMed PubMed Central Google Scholar
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55. https://doi.org/10.1016/s0140-6736(21)02724-0.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–27. https://doi.org/10.1016/s1473-3099(17)30753-3.
Van der Bij AK, Van Mansfeld R, Peirano G, Goessens WH, Severin JA, Pitout JD, et al. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes. Int J Antimicrob Agents. 2011;37(6):513–8. https://doi.org/10.1016/j.ijantimicag.2011.02.010.
Article CAS PubMed Google Scholar
Nagao M, Iinuma Y, Igawa J, Saito T, Yamashita K, Kondo T, et al. Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit. J Hosp Infect. 2011;79(1):49–53. https://doi.org/10.1016/j.jhin.2011.04.018.
Article CAS PubMed Google Scholar
Gibb AP, Tribuddharat C, Moore RA, Louie TJ, Krulicki W, Livermore DM, et al. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7). Antimicrob Agents Chemother. 2002;46(1):255–8. https://doi.org/10.1128/aac.46.1.255-258.2002.
Article CAS PubMed PubMed Central Google Scholar
Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo--lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother. 2005;56(6):1148–51. https://doi.org/10.1093/jac/dki390.
Article CAS PubMed Google Scholar
Voor in ’t holt AF, Severin JA, Lesaffre EM, Vos MC. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58(5):2626–37. https://doi.org/10.1128/aac.01758-13.
Article PubMed PubMed Central Google Scholar
Pirzadian J, Persoon MC, Severin JA, Klaassen CHW, de Greeff SC, Mennen MG, et al. National surveillance pilot study unveils a multicenter, clonal outbreak of VIM-2-producing Pseudomonas aeruginosa ST111 in the Netherlands between 2015 and 2017. Sci Rep. 2021;11(1):21015. https://doi.org/10.1038/s41598-021-00205-w.
Article CAS PubMed PubMed Central Google Scholar
Kanamori H, Weber DJ, Rutala WA. Healthcare outbreaks associated with a water reservoir and infection prevention strategies. Clin Infect Dis. 2016;62(11):1423–35. https://doi.org/10.1093/cid/ciw122.
Catho G, Martischang R, Boroli F, Chraïti MN, Martin Y, Koyluk Tomsuk Z, et al. Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care. Crit Care. 2021;25(1):301. https://doi.org/10.1186/s13054-021-03726-y.
Article PubMed PubMed Central Google Scholar
Pham TM, Büchler AC, Voor in ’t holt AF, Severin JA, Bootsma MCJ, Gommers D, et al. Routes of transmission of VIM-positive Pseudomonas aeruginosa in the adult intensive care unit-analysis of 9 years of surveillance at a university hospital using a mathematical model. Antimicrob Resist Infect Control. 2022;11(1):55. https://doi.org/10.1186/s13756-022-01095-x.
Article PubMed PubMed Central Google Scholar
Liang Q, Chen J, Xu Y, Chen Y, Huang M. Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study. Antimicrob Resist Infect Control. 2022;11(1):89. https://doi.org/10.1186/s13756-022-01103-0.
Article PubMed PubMed Central Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097. https://doi.org/10.1371/journal.pmed.1000097.
Article PubMed PubMed Central Google Scholar
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–8. https://doi.org/10.1016/j.ijsu.2014.07.013.
Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis. 2007;7(4):282–8. https://doi.org/10.1016/s1473-3099(07)70082-8.
Laine L, Perry JD, Lee J, Oliver M, James AL, De La Foata C, et al. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients. J Cyst Fibros. 2009;8(2):143–9. https://doi.org/10.1016/j.jcf.2008.11.003.
Article CAS PubMed Google Scholar
McMullen AR, Yarbrough ML, Wallace MA, Shupe A, Burnham CD. Evaluation of genotypic and phenotypic methods to detect carbapenemase production in gram-negative bacilli. Clin Chem. 2017;63(3):723–30. https://doi.org/10.1373/clinchem.2016.264804.
Article CAS PubMed Google Scholar
Perry JD, Laine L, Hughes S, Nicholson A, Galloway A, Gould FK. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media. J Antimicrob Chemother. 2008;61(5):1057–61. https://doi.org/10.1093/jac/dkn081.
Article CAS PubMed Google Scholar
Zebouh M, Thomas C, Honderlick P, Lemee L, Segonds C, Wallet F, et al. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis. J Cyst Fibros. 2008;7(3):238–43. https://doi.org/10.1016/j.jcf.2007.10.002.
留言 (0)